Sector revisions Imexpharm Corporation

Stocks

End-of-day quote Ho Chi Minh S.E. 2026-10-02			5-day change	1st Jan Change
36,600.00 ^VND	+0.27%		-0.81%	-30.29%

07-19	Imexpharm Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-01	Imexpharm Corporation Announces Cash Dividend for the Year 2025, Payable on July 21, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Visibility	Nbr of analysts
IMEXPHARM CORPORATION	-	1
ELI LILLY AND COMPANY		29
JOHNSON & JOHNSON		22
ABBVIE INC.		28
MERCK & CO., INC.		25
ROCHE HOLDING AG		19
NOVARTIS AG		22
ASTRAZENECA PLC		23
AMGEN INC.		29
GILEAD SCIENCES, INC.		26
NOVO NORDISK A/S		23
PFIZER INC.		26
VERTEX PHARMACEUTICALS INCORPORATED		28
BRISTOL-MYERS SQUIBB COMPANY		24
MCKESSON CORPORATION		14
SANOFI		24
GSK PLC		21
MODERNA, INC.		18
REGENERON PHARMACEUTICALS, INC.		26
MERCK KGAA		14
Average		22
Weighted average by Cap.		25